Targeting IFNGR/IL6R or downstream JAK1/JAK2 to control GvHD
Year: 2018
Type: editorial
Source: Oncotarget
Authors: Kidist Ashami, John F. DiPersio, Jaebok Choi
Institution: Washington University in St. Louis
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
Funder: National Cancer Institute
OpenAlex ID: W2900042071
